Affiliation:
1. Department of Clinical Sciences, Pediatrics Umeå University Umeå Sweden
2. Department of Health Security Finnish Institute for Health and Welfare Helsinki Finland
3. Department of Nutrition University of California Davis California USA
4. Wallenberg Centre for Molecular Medicine (WCMM) Umeå University Umeå Sweden
Abstract
AbstractAimTo examine how reduced iron content and added bovine lactoferrin in infant formula affect the antibody response following routine immunisation.MethodsIn this randomised controlled trial, 180 Swedish formula‐fed infants received, from 6 weeks to 6 months of age, a 2 mg/L iron formula with (n = 72) or without (n = 72) bovine lactoferrin, or a control formula with 8 mg/L iron and no lactoferrin (n = 36). Another 72 infants were recruited as a breastfed reference. Serum immunoglobulin G (IgG) levels against Haemophilus influenzae type b (Hib), diphtheria and tetanus were assessed at four, six and 12 months of age.ResultsWith an equal gender distribution, 180 + 72 term infants were included with a mean age of 7.0 ± 0.7 weeks. At 12 months, infants fed low iron formula showed a significantly higher geometric mean Hib IgG (1.40 μg/mL [1.07–1.83]) compared to the control formula infants (0.67 μg/mL [0.42–1.07]). For all three vaccines, breastfed infants had significantly lower IgG levels at six and 12 months of age.ConclusionExcept for higher Hib IgG levels at 12 months in infants fed low iron formula, the interventions did not affect vaccine IgG response. Unexpectedly, breastfed infants had significantly lower vaccine IgG levels compared to formula‐fed infants.
Funder
Mead Johnson Nutrition
Knut och Alice Wallenbergs Stiftelse